rs146949786
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_005257.6(GATA6):āc.1602A>Gā(p.Thr534=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00444 in 1,612,956 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0035 ( 1 hom., cov: 32)
Exomes š: 0.0045 ( 21 hom. )
Consequence
GATA6
NM_005257.6 synonymous
NM_005257.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.676
Genes affected
GATA6 (HGNC:4174): (GATA binding protein 6) This gene is a member of a small family of zinc finger transcription factors that play an important role in the regulation of cellular differentiation and organogenesis during vertebrate development. This gene is expressed during early embryogenesis and localizes to endo- and mesodermally derived cells during later embryogenesis and thereby plays an important role in gut, lung, and heart development. Mutations in this gene are associated with several congenital defects. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 18-22183025-A-G is Benign according to our data. Variant chr18-22183025-A-G is described in ClinVar as [Benign]. Clinvar id is 240128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-22183025-A-G is described in Lovd as [Likely_benign]. Variant chr18-22183025-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.676 with no splicing effect.
BS2
High AC in GnomAd4 at 529 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA6 | NM_005257.6 | c.1602A>G | p.Thr534= | synonymous_variant | 6/7 | ENST00000269216.10 | NP_005248.2 | |
GATA6 | XM_047437483.1 | c.1602A>G | p.Thr534= | synonymous_variant | 6/7 | XP_047293439.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA6 | ENST00000269216.10 | c.1602A>G | p.Thr534= | synonymous_variant | 6/7 | 1 | NM_005257.6 | ENSP00000269216 | P1 | |
GATA6 | ENST00000581694.1 | c.1602A>G | p.Thr534= | synonymous_variant | 5/6 | 1 | ENSP00000462313 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00348 AC: 529AN: 152152Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
529
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00308 AC: 775AN: 251412Hom.: 3 AF XY: 0.00302 AC XY: 410AN XY: 135886
GnomAD3 exomes
AF:
AC:
775
AN:
251412
Hom.:
AF XY:
AC XY:
410
AN XY:
135886
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00454 AC: 6631AN: 1460686Hom.: 21 Cov.: 31 AF XY: 0.00442 AC XY: 3212AN XY: 726720
GnomAD4 exome
AF:
AC:
6631
AN:
1460686
Hom.:
Cov.:
31
AF XY:
AC XY:
3212
AN XY:
726720
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00347 AC: 529AN: 152270Hom.: 1 Cov.: 32 AF XY: 0.00317 AC XY: 236AN XY: 74464
GnomAD4 genome
AF:
AC:
529
AN:
152270
Hom.:
Cov.:
32
AF XY:
AC XY:
236
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 29, 2023 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 18, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | GATA6: BS1, BS2 - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Atrioventricular septal defect 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at